Biotech Krystal Biotech Announces FDA Acceptance of KB407 IND Application for Cystic Fibrosis Clinical Trial August 2, 2022
Biotech Immunocore announces upcoming oral presentation of initial Phase 1 data of ImmTAC® candidate IMC-F106C targeting PRAME at European Society for Medical Oncology (ESMO) Congress 2022 August 2, 2022
Biotech Caris Life Sciences and Xencor Enter Target Discovery Collaboration and License Agreement for Novel XmAb® Bispecific Antibodies August 2, 2022
Biotech Zentalis Pharmaceuticals, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) August 2, 2022
Biotech SpringWorks Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Conference August 2, 2022
Biotech Day One to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference August 2, 2022
Biotech Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation August 1, 2022